A Vanderbilt University School of Law professor says the copyright system in the U.S. needs changing.
Daniel Gervais, FedEx Research Professor of Law and director of the Vanderbilt Intellectual Property Program, testified Thursday before the U.S. House Committee on the Judiciary's Subcommittee on Courts, Intellectual Property and the Internet, telling the august group that the nation’s copyright system needed a “comprehensive modernization.”
“It may indeed be time to embark on the process that will give us the ‘Next Great Copyright Act,’ as was done three times in the past (Copyright Acts of 1790, 1909 and 1976),” Gervais (pictured) told the congressional subcommittee in prepared testimony, according to a university statement released Thursday.
Gervais said America is best when it produces and exports intellectual property — this fact accentuated by the continuing transition to the digital realm.
“It’s time to get our copyright policy right,” Gervais said.
NextGxDx has retained Sudler & Hennessey – a New York City-based marketing and communications firm – to help the Nashville based technology company market its online genetic testing platform services to healthcare providers, a group including doctor’s groups and genetic counselors. NextGxDx will work with Sudler’s eHealth Group, a division dedicated to working with health information technology companies, like NextGxDx, worldwide.
“Working with the Sudler eHealth Group is an excellent opportunity to drive awareness and Sudler’s knowledge of physician engagement is another innovative step for us to take in connecting with healthcare professionals,” Mark Harris (pictured), NextGxDx CEO, said in the release.
Emerging trends in healthcare focus on cost, quality, and access to care and information. As personalized medicine continues to expand, and as new genetic tests are introduced daily, integration of these tests into clinical practice is a growing challenge for healthcare providers. The innovative NextGxDx solution consolidates and curates data on genetic tests to help users compare and order tests in a simple way that reduces paperwork and streamlines the ordering process leading to more time with their patient.
Saying that Apple's profits are "on the back side of the mountain," David Trainer of New Constructs on Tuesday told viewers of MoneyLife with Chuck Jaffe that the company's shares are worth just $240, more than 40 percent below where they closed trading yesterday. Trainer's method of valuing stocks relies on deep dives into its financials and he said Apple is looking a lot like Dell in its heyday.
Trainer said that if the company can maintain a 75% return on invested capital, “the stock’s worth about 295 bucks. If the return on invested capital drops closer to 50, the stock’s worth closer to 240 bucks, and I think that’s where it ought to be, or where it’s going to go eventually.”
UPDATE: Trainer also talked to CNBC's "Squawk on the Street" Wednesday
Mobile application development firm Metova has promoted Beverly Massengill to lead developer. Massengill joined Metova in January of last year as a developer. She will continue that work but also assist and mentor other developers. Before coming to Franklin-based Metova, Massengill assisted in research on graph-based anomaly detection as a computer science graduate student at Tennessee Technological University.
Health care software developer digiChart has rebranded itself as Artemis, a move unveiled at a New Orleans industry gathering over the weekend. The 17-year-old company's move is meant to better showcase a range of products for the ob-gyn market. Brentwood-based Artemis works with 1,400 doctors and practices in 45 states.